Reed Joanne H, Jackson Jennifer, Christ Daniel, Goodnow Christopher C
Department of Immunology, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW 2010, Australia
Department of Immunology, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
J Exp Med. 2016 Jun 27;213(7):1255-65. doi: 10.1084/jem.20151978. Epub 2016 Jun 13.
Clonal anergy is an enigmatic self-tolerance mechanism because no apparent purpose is served by retaining functionally silenced B cells bearing autoantibodies. Human autoantibodies with IGHV4-3401 heavy chains bind to poly-N-acetyllactosamine carbohydrates (I/i antigen) on erythrocytes and B lymphocytes, cause cold agglutinin disease, and are carried by 5% of naive B cells that are anergic. We analyzed the specificity of three IGHV4-3401 IgG antibodies isolated from healthy donors immunized against foreign rhesus D alloantigen or vaccinia virus. Each IgG was expressed and analyzed either in a hypermutated immune state or after reverting each antibody to its unmutated preimmune ancestor. In each case, the preimmune ancestor IgG bound intensely to normal human B cells bearing I/i antigen. Self-reactivity was removed by a single somatic mutation that paradoxically decreased binding to the foreign immunogen, whereas other mutations conferred increased foreign binding. These data demonstrate the existence of a mechanism for mutation away from self-reactivity in humans. Because 2.5% of switched memory B cells use IGHV4-34*01 and >43% of these have mutations that remove I/i binding, clonal redemption of anergic cells appears efficient during physiological human antibody responses.
克隆无能是一种神秘的自身耐受机制,因为保留携带自身抗体的功能沉默B细胞似乎并无明显目的。带有IGHV4-3401重链的人类自身抗体与红细胞和B淋巴细胞上的多聚N-乙酰乳糖胺碳水化合物(I/i抗原)结合,引发冷凝集素病,并且由5%的无反应性幼稚B细胞携带。我们分析了从针对外来恒河猴D同种异体抗原或痘苗病毒免疫的健康供体中分离出的三种IGHV4-3401 IgG抗体的特异性。每种IgG在高突变免疫状态下表达并分析,或者在将每种抗体回复到未突变的免疫前祖先后进行分析。在每种情况下,免疫前祖代IgG都与携带I/i抗原的正常人B细胞强烈结合。通过单个体细胞突变消除了自身反应性,而这种突变却反常地降低了与外来免疫原的结合,而其他突变则增强了对外来抗原的结合。这些数据证明了人类中存在一种远离自身反应性的突变机制。由于2.5%的转换记忆B细胞使用IGHV4-34*01,其中超过43%具有消除I/i结合的突变,在生理性人类抗体反应期间,无反应性细胞的克隆拯救似乎是有效的。